Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tubbs

Showing results (371-380 of 413) with videos related to

Pageof 42
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2004
Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimensMona Fahmy, Marek Skacel, Terry L Gramlich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of responseR M Bukowski, T Olencki, Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinomaR M Bukowski, P Rayman, L Molto, et al.
The Journal of Urology|May 29, 2003
Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytologyMarek Skacel, Mona Fahmy, Jennifer A Brainard, et al.
Plos Pathogens|April 13, 2006
Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variantAnatoly Urisman, Ross J Molinaro, Nicole Fischer, et al.
Blood|June 5, 2001
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical featuresR M Braziel, D A Arber, M L Slovak, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 1, 2010
Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomasWenjun Zhang, Abigail McElhinny, Alma Nielsen, et al.
Archives of Pathology & Laboratory Medicine|March 8, 2006
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American PathologistsDiane L Persons, Raymond R Tubbs, Linda D Cooley, et al.
Journal of Neurosurgery|April 20, 2006
The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision makingAndrew A Kanner, Susan M Staugaitis, Elias A Castilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group StudyJ W Sweetenham, B Goldman, M L LeBlanc, et al.
Pageof 42

Showing results (371-380 of 413) with videos related to

Sort By:
Pageof 42
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2004
Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimensMona Fahmy, Marek Skacel, Terry L Gramlich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of responseR M Bukowski, T Olencki, Q Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinomaR M Bukowski, P Rayman, L Molto, et al.
The Journal of Urology|May 29, 2003
Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytologyMarek Skacel, Mona Fahmy, Jennifer A Brainard, et al.
Plos Pathogens|April 13, 2006
Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variantAnatoly Urisman, Ross J Molinaro, Nicole Fischer, et al.
Blood|June 5, 2001
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical featuresR M Braziel, D A Arber, M L Slovak, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 1, 2010
Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomasWenjun Zhang, Abigail McElhinny, Alma Nielsen, et al.
Archives of Pathology & Laboratory Medicine|March 8, 2006
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American PathologistsDiane L Persons, Raymond R Tubbs, Linda D Cooley, et al.
Journal of Neurosurgery|April 20, 2006
The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision makingAndrew A Kanner, Susan M Staugaitis, Elias A Castilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group StudyJ W Sweetenham, B Goldman, M L LeBlanc, et al.
Pageof 42